Nomocan Pharmaceuticals LLC

New York, NY

UEI
H9T8M7ZBYAR8
CAGE
7ER28
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
310 E 67th St 1 45, New York, NY 10065, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nomocan Pharmaceuticals LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Phase i - development of therapeutic or preventative technologies for treatment or prevention of pediatric cancers… Contract · 75N91025C00050 National Cancer Institute $499,166
PC has one of the lowest 5-year survival rates among all cancer types, remaining below 10% for the past 40 years,… Contract · 75N91023C00015 National Cancer Institute $354,959

Quick answers

What is Nomocan Pharmaceuticals LLC's UEI?

Nomocan Pharmaceuticals LLC's Unique Entity ID (UEI) in SAM.gov is H9T8M7ZBYAR8.

What is Nomocan Pharmaceuticals LLC's CAGE code?

Nomocan Pharmaceuticals LLC's CAGE code is 7ER28.

What is Nomocan Pharmaceuticals LLC's primary NAICS code?

Nomocan Pharmaceuticals LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Nomocan Pharmaceuticals LLC located?

Nomocan Pharmaceuticals LLC's physical address in SAM.gov is 310 E 67th St 1 45, New York, NY 10065, USA.

Is Nomocan Pharmaceuticals LLC registered in SAM.gov?

Yes. Nomocan Pharmaceuticals LLC's SAM.gov registration is active through July 1, 2027.

What is Nomocan Pharmaceuticals LLC's most recent federal award?

Nomocan Pharmaceuticals LLC's most recent federal contract award is Phase i - development of therapeutic or preventative technologies for treatment or prevention of pediatric cancers… (75N91025C00050), from National Cancer Institute, on September 15, 2025.

On GovTribe

See Nomocan Pharmaceuticals LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login